US pharmaceutical company Gilead has announced plans to start Phase 3 testing of a single-shot vaccine that could prevent HIV infection once a year. If successful, this would be the first effective HIV prevention method in decades. The trial is expected to begin next year, with potential regulatory filings by late 2027.
Source: https://www.statnews.com/2024/12/11/hiv-prevention-gilead-once-a-year-prep